Synapse - Department of Medicine

Results (39669)

Evaluation of trends in imatinib dosing over time: A retrospective cohort study

Meeting Abstract

Hamdan, M.; Yood, M. U.; Sanders, L. M.; Hirji, I.; Hoy, T.; Oliveria, S. A.
Blood (2005)

Induction with combined modality therapy followed by immunomodulated post remission therapy for newly diagnosed acute myeloid leukemia (AML)

Meeting Abstract

Gupta, S.; Weiss, M. A.; Jurcic, J. G.; Chanel, S.; Wilson, B. A.; Biederman, E.; Berman, E.; Scheinberg, D. A.; Maslak, P. G.
Blood (2005)

Fulltext@MSK | Save

Superior outcomes associated with earlier use: Experience with tositumomab and iodine I 131 tositumomab in 1,177 patients (pts) with low-grade, follicular, and transformed non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Gregory, S. A.; Leonard, J. P.; Vose, J. M.; Zelenetz, A. D.; Horning, S. J.; Knox, S. J.; Lister, T. A.; Radford, J. A.; Press, O. W.; Kaminski, M. S.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Economic and demographic patterns influence access to high volume hospitals for surgical resection of colorectal cancer in New York City 2000

Meeting Abstract

Graham, D.; Weiser, M.; Schrag, D.; Wong, D.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Clinical activity of single agent pertuzumab (rhuMab 2C4), a HER dimerization inhibitor, in advanced ovarian cancer (OC): Potential predictive relationship with tumor HER2 activation status

Meeting Abstract

Gordon, M. S.; Matel, D.; Aghajanian, C.; Matulonis, U.; Brewer, M.; Fleming, G.; Hainsworth, J.; Garcia, A. A.; Pegram, M.; Karlan, B.
EJC Supplements (2005)

Fulltext@MSK | Save

Clinical activity of pertuzumab (rhuMab 2C4) in advanced, refractory or recurrent ovarian cancer (OC), and the role of HER2 activation status

Meeting Abstract

Gordon, M. S.; Matei, D.; Aghajanian, C.; Matulonis, U. A.; Brewer, M. A.; Fleming, G. F.; Hainsworth, J. D.; Garcia, A. A.; Pegram, M.; Karlan, B. Y.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Immunogenicity of a BCR-ABL e1a2 p190 translocation in a Balb/C mouse model

Meeting Abstract

Gómez-Nuñez, M.; Pinilla-Ibarz, J.; Dao, T.; Zakhaleva, V.; Korontsvit, T.; May, R. J.; Scheinberg, D. A.
Blood (2005)

Fulltext@MSK | Save

Reliability of computer algorithm-based binding predictions for the identification of leukemia antigens

Meeting Abstract

Gómez-Nuñez, M.; Pinilla-Ibarz, J.; Dao, T.; Korontsvit, T.; Zakhaleva, V.; May, R. J.; Scheinberg, D. A.
Blood (2005)

Fulltext@MSK | Save

Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX, pralatrexate) plus docetaxel in patients with advanced Non-Small Cell Lung Cancer (NSCLC)

Meeting Abstract

Gomez, J.; Azzoli, C.; Krug, L.; Ginsberg, M.; Henry, R.; Tyson, L.; Pizzo, B.; Dunne, M.; Kris, M.; Sirotnak, F.
Lung Cancer (2005)

Fulltext@MSK | Save

Adherence to mammogram (MMG) screening guidelines in BRCA1/2 mutation carriers

Meeting Abstract

Goldfrank, D. J.; Lee, J.; Kauff, N. D.; Hurley, K. E.; Balistreri, L. M.; Hellawell, J.; Borgen, P. I.; Hudis, C. A.; Offit, K.; Robson, M. E.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save